Oxidative polymorphism of debrisoquine in Parkinson's disease
about
Anti-Parkinson's disease drugs and pharmacogenetic considerations.Genetic differences in drug disposition.Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.Metabolism of haloperidol and its tetrahydropyridine dehydration product HPTP.Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families.
P2860
Oxidative polymorphism of debrisoquine in Parkinson's disease
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Oxidative polymorphism of debrisoquine in Parkinson's disease
@ast
Oxidative polymorphism of debrisoquine in Parkinson's disease
@en
Oxidative polymorphism of debrisoquine in Parkinson's disease.
@nl
type
label
Oxidative polymorphism of debrisoquine in Parkinson's disease
@ast
Oxidative polymorphism of debrisoquine in Parkinson's disease
@en
Oxidative polymorphism of debrisoquine in Parkinson's disease.
@nl
prefLabel
Oxidative polymorphism of debrisoquine in Parkinson's disease
@ast
Oxidative polymorphism of debrisoquine in Parkinson's disease
@en
Oxidative polymorphism of debrisoquine in Parkinson's disease.
@nl
P2093
P2860
P356
P1476
Oxidative polymorphism of debrisoquine in Parkinson's disease
@en
P2093
Cobaleda J
Jimenez-Jimenez FJ
Martinez C
Valdivielso MJ
P2860
P304
P356
10.1136/JNNP.53.4.289
P407
P577
1990-04-01T00:00:00Z